Work

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.4737.4737

Authors: Michael (Luhua) Wang, Ajay K. Nooka, Andrew J. Yee, Sheeba K. Thomas, Elizabeth O'Donnell, Jatin Shah, Donna M. Weber, Jonathan L. Kaufman, Sagar Lonial, David Avigan, Noopur Raje

Institutions: The University of Texas MD Anderson Cancer Center, Emory University, Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2344455544

FWCI: 1.886

Cites:

Cited by: 11

Related to: 10